3-normeridamycin

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name3-normeridamycin
Drug Alias Nameprolylmeridamycin
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionNeuroprotectantsDopamine uptake modulators
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Llc
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A